| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forte Biosciences, Inc. | Director | Stock Option (right to buy) | 31K | Mar 20, 2025 | Direct | ||
| Cabaletta Bio, Inc. | Director | Stock Option (Right to Buy) | 22K | Jun 9, 2025 | Direct | ||
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 7.5K | Jul 3, 2025 | Direct |